Cargando…

Low circulating chemerin levels correlate with hepatic dysfunction and increased mortality in decompensated liver cirrhosis

Nutritional status, infections, inflammation and extrahepatic organ dysfunction are critical factors for the progression of chronic liver disease. Chemerin is an immune-metabolically and chemotactically active adipokine and we hypothesized that it is associated with disease severity and prognosis in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Horn, Paul, von Loeffelholz, Christian, Forkert, Franziska, Stengel, Sven, Reuken, Philipp, Aschenbach, René, Stallmach, Andreas, Bruns, Tony
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6006249/ https://www.ncbi.nlm.nih.gov/pubmed/29915268 http://dx.doi.org/10.1038/s41598-018-27543-6

Ejemplares similares

Biomarkers of hepatocellular synthesis in patients with decompensated cirrhosis
por: Gurbuz, Berivan, et al.
Publicado: (2023)

Transcriptional Suppression of the NLRP3 Inflammasome and Cytokine Release in Primary Macrophages by Low-Dose Anthracyclines
por: Köse-Vogel, Nilay, et al.
Publicado: (2019)

Mucosal-Associated Invariant T Cells Redistribute to the Peritoneal Cavity During Spontaneous Bacterial Peritonitis and Contribute to Peritoneal Inflammation
por: Ibidapo-obe, Oluwatomi, et al.
Publicado: (2020)

Genetic variants of TRAF6 modulate peritoneal immunity and the risk of spontaneous bacterial peritonitis in cirrhosis: A combined prospective-retrospective study
por: Mai, Martina, et al.
Publicado: (2017)

Development and validation of a simple and robust model to predict 30-day mortality in patients with Clostridioides difficile-associated enterocolitis
por: Katzer, Katrin Claudia, et al.
Publicado: (2020)

Early ribavirin for hepatitis E virus infection in patients receiving immunosuppressive therapy: a retrospective, observational study
por: Franz, Anika, et al.
Publicado: (2023)

Balance between macrophage migration inhibitory factor and sCD74 predicts outcome in patients with acute decompensation of cirrhosis
por: Wirtz, Theresa H., et al.
Publicado: (2020)

Between fear and courage: Attitudes, beliefs, and behavior of liver transplantation recipients and waiting list candidates during the COVID-19 pandemic
por: Reuken, Philipp A., et al.
Publicado: (2020)

Detection of Liver Dysfunction Using a Wearable Electronic Nose System Based on Semiconductor Metal Oxide Sensors
por: Voss, Andreas, et al.
Publicado: (2022)

Immunomodulatory receptor VSIG4 is released during spontaneous bacterial peritonitis and predicts short-term mortality
por: Reißing, Johanna, et al.
Publicado: (2021)

Risk Factors for Multi-Drug Resistant Pathogens and Failure of Empiric First-Line Therapy in Acute Cholangitis
por: Reuken, Philipp A., et al.
Publicado: (2017)

Correction: Risk Factors for Multi-Drug Resistant Pathogens and Failure of Empiric First-Line Therapy in Acute Cholangitis
por: Reuken, Philipp A., et al.
Publicado: (2017)

Associations of circulating chemerin and adiponectin concentrations with hepatic steatosis
por: Levin, Lena-Maria, et al.
Publicado: (2019)

Attenuated antigen-specific T cell responses in cirrhosis are accompanied by elevated serum interleukin-10 levels and down-regulation of HLA-DR on monocytes
por: Peter, Jack, et al.
Publicado: (2013)

Soluble mannose receptor CD206 and von Willebrand factor are early biomarkers to identify patients at risk for severe or necrotizing acute pancreatitis
por: Reuken, Philipp A., et al.
Publicado: (2022)

NT-proBNP as a biomarker for hyperdynamic circulation in decompensated cirrhosis
por: Maslennikov, Roman, et al.
Publicado: (2018)

Treatment of Hepatitis B in Decompensated Liver Cirrhosis
por: Guan, Richard, et al.
Publicado: (2011)

Circulating Chemerin Is Elevated in Women With Preeclampsia
por: Bartho, Lucy A, et al.
Publicado: (2023)

Diastolic Dysfunction Is a Predictor of Poor Survival in Patients with Decompensated Cirrhosis
por: Behera, Manas Kumar, et al.
Publicado: (2021)

Improving Survival in Decompensated Cirrhosis
por: Mukerji, Amar Nath, et al.
Publicado: (2012)

Management options in decompensated cirrhosis
por: Shah, Neeral L, et al.
Publicado: (2015)

COVID-19 in decompensated cirrhosis
por: Rela, Mohamed, et al.
Publicado: (2020)

Decompensation of Cirrhosis: An Unusual Cause
por: Rudra, Omkar S, et al.
Publicado: (2022)

Folgen nach SARS-CoV-2-Infektion einschließlich Post-COVID-Syndrom
por: Quickert, Stefanie, et al.
Publicado: (2023)

Liver-HERO: hepatorenal syndrome-acute kidney injury (HRS-AKI) treatment with transjugular intrahepatic portosystemic shunt in patients with cirrhosis—a randomized controlled trial
por: Ripoll, Cristina, et al.
Publicado: (2023)

SACRED: Effect of simvastatin on hepatic decompensation and death in subjects with high-risk compensated cirrhosis: Statins and Cirrhosis: Reducing Events of Decompensation
por: Kaplan, David E., et al.
Publicado: (2021)

COVID‐19 mortality in cirrhosis is determined by cirrhosis‐associated comorbidities and extrahepatic organ failure: Results from the multinational LEOSS registry
por: Brozat, Jonathan F., et al.
Publicado: (2022)

COVID-19 in patients with cirrhosis: insights from the multinational LEOSS registry
por: Brozat, Jonathan Frederik, et al.
Publicado: (2022)

The Relationship between Renal Dysfunction and Abnormalities of the Immune System in Patients with Decompensated Cirrhosis
por: Kakazu, Eiji, et al.
Publicado: (2012)

Cardiac diastolic dysfunction predicts poor prognosis in patients with decompensated liver cirrhosis
por: Lee, Soon Kyu, et al.
Publicado: (2018)

Management of decompensated liver cirrhosis in the surgical intensive care unit
por: Kasper, Philipp, et al.
Publicado: (2023)

Plasma levels of circulating DNA are associated with outcome, but not with activation of coagulation in decompensated cirrhosis and ACLF
por: Blasi, Annabel, et al.
Publicado: (2019)

Chemerin in peritoneal sepsis and its associations with glucose metabolism and prognosis: a translational cross-sectional study
por: Horn, Paul, et al.
Publicado: (2016)

Improving Survival in Patients with Decompensated Cirrhosis
por: Amarapurkar, Deepak, et al.
Publicado: (2011)

Recompensation of Decompensated Hepatitis B Cirrhosis: Current Status and Challenges
por: Zhao, Hong, et al.
Publicado: (2020)

Evolution of care in cirrhosis: Preventing hepatic decompensation through pharmacotherapy
por: Lee, Seohyuk, et al.
Publicado: (2023)

Chemerin-induced mitochondrial dysfunction in skeletal muscle
por: Xie, Qihai, et al.
Publicado: (2015)

Monocyte dysfunction in decompensated cirrhosis is mediated by the prostaglandin E2-EP4 pathway
por: Maini, Alexander A., et al.
Publicado: (2021)

Insulin and Metformin Regulate Circulating and Adipose Tissue Chemerin
por: Tan, Bee K., et al.
Publicado: (2009)

Increased circulating chemerin in patients with advanced carotid stenosis
por: Kammerer, Adrian, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_5h1m53h9lrf47f0snkgacspgal